Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Cancer|September 1, 1989
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant diseaseE T Creagan, S Frytak, H J Long, et al.
American Journal of Clinical Oncology|December 1, 1988
Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term respondersE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|January 1, 1988
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinomaE T Creagan, H J Long, S Frytak, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of diaziquone in patients with advanced carcinoma of the lungS Frytak, R T Eagan, E T Creagan, et al.
American Journal of Clinical Oncology|April 1, 1991
A technetium-labeled monoclonal antibody for imaging metastatic melanomaS Frytak, E T Creagan, M L Brown, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1999
Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathyE Galanis, S Frytak, K M Rowland, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomasJ H Edmonson, S Frytak, L Letendre, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer Treatment Reports|July 1, 1976
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancerR T Eagan, D T Carr, S Frytak, et al.
Cancer Treatment Reports|September 1, 1978
Surgically proven pulmonary metastases not demonstrated by computed chest tomographyE T Creagan, S Frytak, P Pairolero, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Cancer|September 1, 1989
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant diseaseE T Creagan, S Frytak, H J Long, et al.
American Journal of Clinical Oncology|December 1, 1988
Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term respondersE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|January 1, 1988
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinomaE T Creagan, H J Long, S Frytak, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of diaziquone in patients with advanced carcinoma of the lungS Frytak, R T Eagan, E T Creagan, et al.
American Journal of Clinical Oncology|April 1, 1991
A technetium-labeled monoclonal antibody for imaging metastatic melanomaS Frytak, E T Creagan, M L Brown, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1999
Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathyE Galanis, S Frytak, K M Rowland, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomasJ H Edmonson, S Frytak, L Letendre, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer Treatment Reports|July 1, 1976
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancerR T Eagan, D T Carr, S Frytak, et al.
Cancer Treatment Reports|September 1, 1978
Surgically proven pulmonary metastases not demonstrated by computed chest tomographyE T Creagan, S Frytak, P Pairolero, et al.
Pageof 11